EOLS
Evolus, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$9.30
+2.76%Forward multiples
Based on analyst estimates
- P/E forward
- 81.59x
- P/E 2026E
- —
- P/E 2027E
- 36.83x
- P/E 2028E
- 15.37x
- P/S forward
- 1.69x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -19.88x
- Price / sales
- 1.94x
- Price / cash flow
- -39.94x
Enterprise value
- Enterprise value
- $733.9M
- EV / sales
- 2.32x
- EV / EBITDA
- -71.73x
- EV / EBIT
- -31.64x
- Market cap
- $614.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026